EventsThe 4th International Electronic Conference on Biosensors
Published
This submission belongs to the session I. Optical and Photonic Biosensors of the event The 4th International Electronic Conference on Biosensors
Published date
28 May, 2024
Academic Editor
author-avatarJun-Jie Zhu
Citation
Rui C. Martins, Teresa Barroso, Maria Soares, Filipe Monteiro-Silva, Carla Queiros, Diogo Macedo, Marta Oliveira, Miguel Angelo Sousa, Rita Antunes, Miguel Furtado, Tiago Gregório, Spectroscopy Human Hemogram Analysis - A feasiblity case study, in Proceedings of The 4th International Electronic Conference on Biosensors, 20 May–22 May 2024, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Spectroscopy Human Hemogram Analysis - A feasiblity case study

image
Miguel Angelo Sousa 4
Miguel Furtado 4
Tiago Gregório 4,6
1. INESC TEC - Institute for Systems and Robotics and Computer Engineering, Technology and Science - Campus da FEUP, Porto - Portugal, Portugal
2. TOXRUN—Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal, Portugal
3. LAQV-REQUIMTE, Faculty of Sciences, University of Porto, R. Campo Alegre, 4169-007 Porto, Portugal, Portugal
4. CHVNGE - Hospital Centre of Vila Nova de Gaia e Espinho, R. Conceição Fernandes - Vila Nova de Gaia, Portugal, Portugal
5. Hospital CUF Porto - Estr. da Circunvalação 14341, 4100-180 Porto, Portugal
6. CINTESIS- Centro de Investigação em Tecnologias da Saúde. R. Dr. Plácido Costa, 4200-450 Porto- Portuga
Abstract

Blood hemograms are an essential part of the clinical pathology diagnosis. These are currently performed in the clinical laboratory using automated hematology machines (AHM) to discriminate blood cells by capillary laser scattering technology. Despite all the efforts in this miniaturization through microfluidics, this approach may not be appropriate for use at point-of-care (POC) under harsh or non-ideal operational conditions. AHM already uses low volumes of blood samples, but the blood is still collected by traditional venipuncture, and quantification of cells and hemoglobin still requires the use of reagents. A way to allow POC technology to be used in the harsh conditions of emergency medicine is to remove both venipuncture procedures and reagents.Research in canines and felines has demonstrated that hemogram analysis using reagent-less spectral technology at the point-of-care (POC) with an ultra-portable device that requires a single drop of blood is feasible for quantification with analytical-grade quality red blood cells (RBC), hemoglobin (Hgb), and hematocrit (HTC). Such POC uses solely ultraviolet, visible, and near-infrared spectroscopy to unscramble spectral information related to blood composition using self-learning artificial intelligence, providing unequivocal advantages in terms of convenience, real-time results, pain-free procedure, and reduced risk of infection.Herein, we demonstrate the feasibility of direct detection of RBC, Hgb, and HTC counts in human blood using spectral POC technology for medical applications. The results showed excellent agreement in terms of correlation (R) and total error (TE) against the ground-truth method, where i. RBC: R2=0.84-0.77, TE=7.3 -5.7%; ii. Hgb: R=0.74-0.85 and TE=4.9-6.4%; and iii. HTC: R=0.74-0.80 and TE=5.5-7.6%.Spectral POC demonstrates promise as a method for conducting rapid and simple point-of-care hemogram analyses in human patients. Further research is necessary to enhance and confirm the instrument's accuracy and to expand the range of parameters examined.

Keywords
Point-of-Care
Hemogram
Spectroscopy
Reagent-Free
Blood Serum Clinical Chemistry Through Spectroscopy - an assemement case study towards direct clinical chemistry in a single drop of blood
Detecting Insect Herbivore Attacks Using Metal–Organic Framework (MOF)-Based Colorimetric–Piezoelectric Sensor